Pregled bibliografske jedinice broj: 538270
Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells
Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells // European journal of haematology, 86 (2011), 6; 488-495 doi:10.1111/j.1600-0609.2011.01605.x (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 538270 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells
Autori
Basak, Grzegorz W. ; Jakšić, Ozren ; Koristek, Zdenek ; Mikala, Gabor ; Bašić-Kinda, Sandra ; Mayer, Jiri ; Masszi, Tamas ; Giebel, Sebastian ; Labar, Boris ; Wiktor-Jedrzejczak, Wieslaw
Izvornik
European journal of haematology (0902-4441) 86
(2011), 6;
488-495
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
plerixafor ; stem cell mobilization ; myeloma ; autologous stem cell transplantation
Sažetak
A proportion of patients with multiple myeloma (MM) who have already undergone autologous stem cell transplantation (autoSCT) might benefit from a further transplantation. For this, they might need to undergo another round of stem cell mobilization. We analyzed retrospectively the outcomes of stem cell mobilization with plerixafor and granulocyte colony-stimulating factor (G-CSF) in a group of 30 patients who had undergone autoSCT previously, and in 46 other patients. The previously transplanted patients were significantly different from the remaining patients with respect to the intensity and number of previous therapies. We observed that the median peripheral blood concentration of CD34+ cells after the first administration of plerixafor was lower in previously transplanted (19 cells/mu L) than in other patients (30 cells/mu L, P < 0.05). Despite a comparable number of apheresis sessions being performed, the median total yield of CD34+ cells was significantly lower in the previously transplanted than in the remaining patients (2.8 x 106 cells/kg vs. 4.2 x 106 cells/kg, P < 0.05). However, successful collection of at least 2.0 x 106 CD34+ cells/kg was achieved finally in a similar proportion of previously transplanted and other patients (70% vs. 82.6%). Our data suggest that stem cell mobilization with plerixafor and G- CSF might overcome the negative effect of prognostic factors for poor stem cell mobilization in patients with MM who have undergone autoSCT previously.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1081872-1913 - LEUKEMIJE I TRANSPLANTACIJA KRVOTVORNIH MATIČNIH STANICA (Duraković, Nadira, MZOS ) ( CroRIS)
198-1980955-0953 - Imunobiologija kronične B-limfocitne leukemije i mikrookoliš (Jakšić, Ozren, MZOS ) ( CroRIS)
Ustanove:
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE